Atlas Trials

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Clinical trial NCT05042258 · RECRUITING

Trial details

NCT number
NCT05042258
Sponsor
Northwestern University
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Atopic DermatitisSleep Disturbance
Start date
2024-08-12
Primary completion
2027-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.